Abstract
Back in 2003, Brazil’s and Mozambique’s presidents, Luiz Inácio Lula da Silva and Joaquim Chissano, agreed to set up the first pharmaceutical factory in Mozambique, to be entirely owned by the national government. The project — widely known as the Brazil-Mozambican anti-retro-viral factory because of its commitment to produce AIDS drugs — still represents the single most expensive and eye-catching project of Brazil’s South-South cooperation programme in the health sector.
Chapter PDF
Similar content being viewed by others
Keywords
- National Health Service
- Generic Drug
- Pharmaceutical Market
- Development Cooperation
- Southern African Development Community
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Editor information
Editors and Affiliations
Rights and permissions
This chapter is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
Copyright information
© 2016 Giuliano Russo and Lícia de Oliveira
About this chapter
Cite this chapter
Russo, G., de Oliveira, L. (2016). South-South Collaboration in Pharmaceuticals: Manufacturing Anti-retroviral Medicines in Mozambique. In: Mackintosh, M., Banda, G., Tibandebage, P., Wamae, W. (eds) Making Medicines in Africa. International Political Economy Series. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-137-54647-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-137-54647-0_6
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-137-57133-5
Online ISBN: 978-1-137-54647-0
eBook Packages: Economics and FinanceEconomics and Finance (R0)